Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Bufalin–CRISPR Nanomedicine in Colorectal Cancer
2026-11-22
The paper examines a calcium-lactate/phospholipid nanoparticle carrying bufalin and CRISPR-Cas9/sgRNA directed against CD47 in CT26 colorectal-cancer models. Its readouts connect tumor-cell stress, pyroptosis, immunogenic-cell-death markers, macrophage state, phagocytosis, CD47 editing, biodistribution, and tumor growth. Interpretation remains limited to the reported cellular and murine models.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-21
The paper examines whether ENO1 links postinfarction macrophage metabolism to inflammatory polarization and cardiac remodeling. Its preclinical data support a model in which acid-responsive delivery of siENO1 alters glycolysis, lactate-associated signaling, inflammatory macrophage features, and several myocardial injury readouts.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-20
A preclinical study examines whether ENO1 links glycolytic remodeling with inflammatory macrophage behavior after myocardial infarction and tests an acid-responsive nanocarrier for targeted siRNA delivery. The findings support a mechanistic model involving glycolysis, lactate, and KLF4, while remaining bounded by cellular and murine disease models.
Targeted CSN2 Expression in Pharming Rabbits
2026-11-20
A 2025 study evaluates whether placing a tdTomato reporter at the endogenous rabbit CSN2 locus can connect recombinant-protein expression to native β-casein regulation and support inheritance across generations. The findings constitute a proof of concept, while the reporter-only design, small animal set, and unvalidated expansion strategy limit broader interpretation.
Ionomycin and Lipid-Asymmetry Control
2026-11-19
Ionomycin is best interpreted as an upstream calcium perturbant in studies of membrane organization. Evidence from a recent plasma-membrane study shows that calcium-dependent phospholipid scrambling can selectively remodel hydrophobic-molecule transport without causing nonspecific membrane leakage, making probe accumulation a state-dependent readout rather than a simple measure of passive entry.
Annexin V Signals in Postinfarction Repair
2026-11-19
Annexin V fluorescence can provide a useful apoptosis-associated readout in studies of cardiac injury, but it does not by itself establish irreversible cell death or validate the ENO1–lactate–KLF4 mechanism. Li et al.’s preclinical work supports a mechanistic model linking macrophage metabolism to postinfarction repair while leaving important questions about measurement specificity, causal hierarchy, and translation unresolved.
When Apoptosis Readouts Change Meaning
2026-11-18
Annexin V fluorescence can report phosphatidylserine exposure without proving irreversible cell death. In postinfarction research, its meaning depends on whether it is used as a cell-state measurement, a tissue-injury endpoint, or part of a broader metabolic mechanism.
Annexin V Signals in Postinfarction Repair
2026-11-18
Annexin V fluorescence reports phosphatidylserine exposure, while a 2026 study links ENO1, lactate, KLF4 and macrophage state to postinfarction repair. The readout is informative but not standalone proof of apoptosis or therapeutic causality.
Annexin V Readouts in Cardiac Repair
2026-11-17
Annexin V fluorescence can quantify cell-surface phosphatidylserine exposure, but that downstream signal cannot by itself establish apoptosis mechanism or prove that ENO1 silencing caused cardiac repair. In the postinfarction study considered here, the assay concept is best understood as one component of a broader evidence chain linking macrophage metabolism, inflammatory state, cardiomyocyte injury, and tissue remodeling.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-17
A preclinical study links ENO1 activity in post-infarction macrophages to glycolytic remodeling, inflammatory polarization, and tissue injury. Its acid-responsive nanocarrier approach provides mechanistic evidence for macrophage-focused siRNA delivery in murine myocardial infarction, while remaining limited to experimental models.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-16
A paper-centred interpretation of how ENO1-linked metabolic remodeling in infarct-associated macrophages was investigated using an acid-responsive siRNA nanocarrier, with emphasis on mechanism, cell targeting, preclinical cardiac outcomes, and evidence boundaries.
Wnt, O-GlcNAcylation and Bone Formation
2026-11-16
The paper examines how Wnt signaling reshapes glucose metabolism during osteoblast formation. Its findings connect O-GlcNAcylation, aerobic glycolysis and PDK1 stability, while mouse studies show that O-GlcNAcylation contributes to—but does not fully account for—Wnt-associated bone formation.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-15
A preclinical study examines how ENO1-associated glycolytic remodeling shapes macrophage behavior after myocardial infarction and evaluates an acid-responsive siRNA nanocarrier as a mechanistic test. The reported findings connect ENO1 silencing with altered lactate–KLF4 signaling, reduced inflammatory features, macrophage-biased delivery, and improved cardiac tissue measurements in mice.
ENO1, Macrophage Metabolism, and Cardiac Repair
2026-11-14
A preclinical study examines whether ENO1 connects inflammatory macrophage metabolism with post-infarction tissue remodeling, and whether an acid-responsive nanocarrier can test that mechanism in cellular and murine models. The reported findings support a metabolism-linked model involving glycolysis, lactate, and KLF4, while leaving important questions about mechanism, durability, and translation unresolved.
When Apoptosis Signals Change Meaning
2026-11-13
An Annexin V signal is not a diagnosis of apoptosis in isolation. Its meaning depends on the cell population, injury model, membrane state, and the upstream mechanism being tested. The postinfarction ENO1 study illustrates how a fluorescence readout can support a broader causal argument without proving that mechanism by itself.